Justin Keywood

Q: How accurate are Justin Keywood's stock ratings?

About 49% of Justin's ratings were profitable over a one-year hold, with an average return of -0.9% per rating, measured by 13Foresight from historical prices.

Q: How is Justin ranked?

Justin Keywood is ranked #1136 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

Stifel Nicolaus

Wall Street Analyst

★★★☆☆

#1136

on 13Foresight · ranked by our own returns

52%

Success Rate

-0.9%

Average Return

33 of 64 calls profitable · -4.4% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compared To ⓘ

S&P 500 (SPY)

📈 Across the calls we could measure, roughly 52% of Justin Keywood's ratings turned a profit when each position was held for 1 year — averaging -0.9% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

153 Buy 8 Hold 1 Sell

Justin's Stock Coverage 28 ratings · 2026-09-20

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return	vs S&P 500 ⓘ
TSE:NPTH Neupath Health Inc.	Sep 16, 2026	BUY	Strong Buy +25.8% avg upside 1 analyst	$0.68 25.84% Upside	·	·
TSE:DHT.UN DRI Healthcare	Sep 16, 2026	BUY	Strong Buy +18.4% avg upside 6 analysts	$26.00 50.56% Upside	+1.2%	·
TSE:SIS Savaria	Sep 15, 2026	BUY	Strong Buy +5.0% avg upside 7 analysts	$35.00 19.94% Upside	+2.1%	·
TSE:ATS ATS Corporation	Sep 15, 2026	BUY	Buy +64.1% avg upside 11 analysts	$44.00 62.38% Upside	+1.7%	·
TSE:CHLT Custom Health Holdings Inc.	Sep 11, 2026	BUY	Strong Buy +59.9% avg upside 1 analyst	$12.00 59.85% Upside	+7.3%	·
TSE:WELL WELL Health Technologies Corp	Sep 10, 2026	BUY	Strong Buy +63.2% avg upside 11 analysts	$8.50 100.49% Upside	+5.2%	·
TSE:HLS HLS Therapeutics Inc	Aug 14, 2026	HOLD	Strong Buy +129.9% avg upside 4 analysts	$4.45 13.86% Upside	+0.3%	·
TSE:CPH Cipher Pharmaceuticals	Aug 13, 2026	BUY	Strong Buy -44.4% avg upside 4 analysts	$20.00 36.31% Upside	+4.9%	·
TSE:APTX Apotex Health Corp.	Aug 13, 2026	BUY	Strong Buy +21.4% avg upside 10 analysts	$42.00 26.39% Upside	-6.3%	·
TSE:AIDX HEALWELL AI	Aug 10, 2026	BUY	Strong Buy +195.2% avg upside 10 analysts	$2.25 208.27% Upside	+0.0%	·
TSE:JWEL Jamieson Wellness Inc	Aug 07, 2026	HOLD	Strong Buy -12.6% avg upside 9 analysts	$45.75 0.70% Upside	+0.4%	·
TSE:VHI Vitalhub	Aug 07, 2026	BUY	Strong Buy +82.6% avg upside 9 analysts	$11.00 49.50% Upside	-6.7%	·
TSE:GUD Knight Therapeutics	Aug 07, 2026	BUY	Strong Buy -10.7% avg upside 7 analysts	$11.00 7.32% Upside	+5.0%	·
WELL Welltower	Aug 05, 2026	BUY	Strong Buy -14.8% avg upside 34 analysts	$6.07 97.43% Downside	-3.2%	·
TSE:KBL K-Bro Linen	Jul 31, 2026	BUY	Strong Buy +5.8% avg upside 4 analysts	$52.00 23.58% Upside	-11.0%	·
TSE:CRRX CareRx	Jul 31, 2026	BUY	Strong Buy +69.2% avg upside 5 analysts	$4.50 41.02% Upside	-11.5%	·
NGEN NervGen Pharma	May 21, 2026	BUY	Strong Buy +373.9% avg upside 9 analysts	$6.00 192.61% Upside	-44.3%	·
AIDX 20/20 Biolabs, Inc.	Mar 20, 2026	BUY	Strong Buy +629.5% avg upside 2 analysts	$1.79 284.03% Upside	-76.7%	·
TSE:ZYUS ZYUS Life Sciences	Dec 12, 2025	BUY	Strong Buy +150.0% avg upside 1 analyst	$1.50 149.97% Upside	·	·
TSE:MDP Medexus Pharmaceuticals Inc	Feb 06, 2025	HOLD	Strong Buy +10.9% avg upside 5 analysts	$3.45 31.64% Downside	-6.9%	·
TSE:QST Questor Technology	Apr 28, 2023	HOLD	Buy +263.8% avg upside 3 analysts	—	-31.9%	·
TSE:NEWU.H Newtopia	Dec 16, 2022	HOLD	Hold 1 analyst	—	·	·
TSE:OGI Organigram Global	Apr 03, 2020	HOLD	Strong Buy +211.2% avg upside 11 analysts	—	+89.5%	·
NEPTF Neptune Wellness Solutions	Dec 06, 2019	HOLD	Strong Buy +403357734.0% avg upside 7 analysts	—	·	·
TSE:LPS Legend Power Systems	May 17, 2019	HOLD	Hold +87.5% avg upside 2 analysts	—	-41.2%	·
TSE:SJ Stella-Jones	May 17, 2019	HOLD	Buy +27.8% avg upside 9 analysts	—	-28.1%	·
TSE:TCS TECSYS Inc. J	May 17, 2019	HOLD	Strong Buy +13.4% avg upside 7 analysts	—	+65.7%	·
TSE:CMG Computer Modelling	May 17, 2019	HOLD	Hold +102.9% avg upside 10 analysts	—	-32.0%	·

🔒 23 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Justin Keywood — Frequently Asked Questions

How accurate are Justin Keywood's stock ratings?

Based on the calls 13Foresight could measure, about 49% of Justin's ratings were profitable over a one-year hold, with an average return of -0.9% per rating, or -46.7% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.

How is Justin ranked on 13Foresight?

Justin Keywood is currently ranked #1136 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Justin cover?

Justin most recently has ratings on TSE:NPTH, TSE:DHT.UN, TSE:SIS, TSE:ATS, TSE:CHLT, TSE:WELL, TSE:HLS, TSE:CPH, TSE:APTX, TSE:AIDX, TSE:JWEL, TSE:VHI and 16 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Justin Keywood

Rating Distribution

Welcome to 13Foresight!